Consumer opinion and effectiveness of direct-to-consumer advertising

Journal of Consumer Marketing

Volumn 24, Issue 5, 2007, Pages 283-293

  Spake, Deborah F ^a   Joseph, Mathew ^a  

^a University of South Alabama   (United States)

Author keywords

Advertising; Consumer behaviour; Pharmaceutical products; Public policy

Indexed keywords

EID: 34547690696     PISSN: 07363761     EISSN: None     Source Type: Journal    
DOI: 10.1108/07363760710773102     Document Type: Article

References (33)

1. Advertising Age (2006), "Domestic ad spending by category, 2006 edition", Advertising Age, available at: http://adage.com/datacenter/ article?articleid=110123 (accessed August 1, 2006).
2. American College of Physicians (2005), "Statement of the American College of Physicians for the record of the public hearing on 'consumer-directed promotion of regulated medical products'", available at: www.acponline.org/hpp/dtcfda.pdf (accessed April 26, 2006).
3. American Medical Association (1993), "H-105.988 direct-to-consumer advertising (DTCA) of prescription drugs", available at: www.ama-assn.org/apps/pfnew/pfonline?fn=browse&doc=policyfiles/hne/h-105. 988.htm (accessed April 26, 2006).
4. Avorn, J. (2003), "Advertising and prescription drugs: promotion, education, and the public's health", Health Affairs, Vol. 22 No. 1, pp. 104-8.
5. Avorn, J., Chen, M. and Hartley, R. (1982), "Scientific versus commercial sources of influence on the prescribing behavior of physicians", American Journal of Medicine, Vol. 73 No. 1, pp. 4-8.
6. Beales, J.H. III (1991), "What state regulators should learn from FTC experience in regulating advertising", Journal of Public Policy and Marketing, Vol. 10, pp. 101-17.
7. Bell, R.A., Kravitz, R.L. and Wilkes, M.S. (2000a), "Direct-to- consumer prescription drug advertising, 1989-1998: a content analysis of conditions, targets, inducements, and appeals", Journal of Family Practice, Vol. 49 No. 4, pp. 329-35.
8. Bell, R.A., Wilkes, M.S. and Kravitz, R.L. (1999), "Advertisement- induced prescription drug requests: patients' anticipated reactions to a physician who refuses", Journal of Family Practice, Vol. 48 No. 6, pp. 446-52.
9. Bell, R.A., Wilkes, M.S. and Kravitz, R.L. (2000b), "The educational value of consumer-targeted prescription drug print advertising", Journal of Family Practice, Vol. 49 No. 12, pp. 1092-8.
10. Borzo, G. (1997), "Consumer drug ads booming: FDA reviews restrictions", American Medical News, Vol. 40 No. 6, pp. 1-37.
11. Calfee, J.E. (2002), "Public policy issues in direct-to-consumer advertising of prescription drugs", Journal of Public Policy and Marketing, Vol. 21 No. 2, pp. 174-93.
12. Cohen, J.B. (2002), "Introductory comments: direct-to-consumer prescription drug advertising: evaluating regulatory policy in the United States and New Zealand", Journal of Public Policy and Marketing, Vol. 21 No. 2, pp. 172-3.
13. Committee on Drugs (1991), "Prescription drug advertising direct to the consumer", Pediatrics, Vol. 88 No. 1, pp. 174-5.
14. Consumer Reports (2006), "Prescription for trouble: common drugs, hidden dangers, tens of millions of people at risk", Consumer Reports, Vol. 71 No. 1, pp. 34-9.
15. Crawford, A. (2001), "Advertisers weighing up where ax will fall", Ad Age Global, Vol. 1 No. 8, p. 5.
16. Curfman, G.D., Morrissey, S. and Drazen, J.M. (2005), "Expression of concern: Bombardier et al., 'comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis', New England Journal of Medicine 2000; 343: 1520-8", New England Journal of Medicine, Vol. 353 No. 26, pp. 2813-4.
17. Deshpande, A., Menon, A. and Perri, M. III (2004), "Direct-to- consumer advertising and its utility in health care decision making: a consumer perspective", Journal of Health Communication, Vol. 9 No. 6, pp. 499-513.
18. Farris, P.W. and Wilkie, W.L. (2005), "Marketing scholars' roles in the policy arena: an opportunity for discourse on direct-to-consumer advertising", Journal of Public Policy and Marketing, Vol. 24 No. 1, pp. 3-6.
19. Gottlieb, S. (2002a), "A fifth of Americans contact their doctor as a result of direct to consumer drug advertising", British Medical Journal, Vol. 325, p. 854.
20. Gottlieb, S. (2002b), "Congress criticises drugs industry for misleading advertising", British Medical Journal, Vol. 325, p. 1379.
21. Gönül, G.F., Carter, F. and Wind, J. (2000), "What kind of patients and physicians value direct-to-consumer advertising of prescription drugs", Health Care Management Science, Vol. 3 No. 3, pp. 215-26.
22. Hollon, M.F. (1999), "Direct-to-consumer marketing of prescription drugs: creating consumer demand", JAMA: The Journal of the American Medical Association, Vol. 281 No. 4, pp. 382-4.
23. Joseph, M., Stone, G., Haper, J., Stockwell, E., Johnson, K. and Huckaby, J. (2005), "The effect of manufacturer-to-consumer prescription drug advertisements: an exploratory investigation", Journal of Medical Marketing, Vol. 5 No. 3, pp. 233-44.
24. Kaiser Family Foundation (2004), "Prescription drug trends", available at: www.kff.org/rxdrugs/3057-03.cfm (accessed June 5, 2006).
25. Kim, H. (2002), "Top 10 global ad markets", Ad Age Global, Vol. 2 No. 8, pp. 18-20.
26. Kravitz, R.L., Epstein, R.M., Feldman, M.D., Franz, C.E., Azari, R., Wilkes, M.S., Hinton, L. and Franks, P. (2005), "Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial", JAMA: The Journal of the American Medical Association, Vol. 293 No. 16, pp. 1995-2002.
27. Lexchin, J. and Mintzes, B. (2002), "Direct-to-consumer advertising of prescription drugs: the evidence says no", Journal of Public Policy and Marketing, Vol. 21 No. 2, pp. 194-201.
28. Macias, W. and Lewis, L.S. (2004), "A content analysis of direct-to-consumer (DTC) prescription drug web sites", Journal of Advertising, Vol. 32 No. 4, pp. 43-56.
29. Mehta, A. and Purvis, S.C. (2003), "Consumer response to print prescription drug advertising", Journal of Advertising Research, Vol. 43, June, pp. 194-206.
30. Petroshius, S.M., Titus, P.A. and Hatch, K.J. (1995), "Physician attitudes toward pharmaceutical drug advertising", Journal of Advertising Research, Vol. 35 No. 6, pp. 41-51.
31. Sheehan, K.B. (2003), "Balancing acts: an analysis of food and drug administration letters about direct-to-consumer advertising violations", Journal of Public Policy and Marketing, Vol. 22 No. 2, pp. 159-69.
32. United States General Accounting Office (2002), "Prescription drugs: FDA oversight of direct-to-consumer advertising has limitations", Report No. GAO-03-177, available at: www.gao.gov/new.items/d03177.pdf (accessed June 5, 2006).
33. Weissman, J.S., Blumenthal, D., Silk, A.J., Newman, M., Zapert, K., Leitman, R. and Feibelmann, S. (2004), "Physicians report on patient encounters involving direct-to-consumer advertising", Health Affairs, available at: http://content.healthaffairs.org/cgi/content/abstract/hlthaff.w4. 219v1 (accessed June 5, 2006).